Bluejay Diagnostics (BJDX) Other Working Capital Changes (2020 - 2026)
Bluejay Diagnostics' (BJDX) quarterly Other Working Capital Changes came in at -$6019.0 in Q1 2026, up 95.73% year-on-year from -$3075.2 in Q1 2025, and down 104.65% quarter-over-quarter from $129306.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has disclosed Other Working Capital Changes across 7 years of filings, most recently posting -$6019.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$6019.0, up 95.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$199041.0 (up 40.14% YoY), and the FY2025 annual result was -$333881.0, down 122.11% from the prior year.
- Other Working Capital Changes came in at -$6019.0 for Q1 2026 at Bluejay Diagnostics, down from $129306.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q4 2022 to a low of -$703542.0 in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$148048.0 (2024), against an average of -$80921.8.
- Across the five-year window, Other Working Capital Changes plunged 39284.75% in 2022 and surged 244.06% in 2023, its largest moves.
- Bluejay Diagnostics' Other Working Capital Changes stood at $1.0 million in 2022, then slumped by 169.89% to -$703542.0 in 2023, then jumped by 69.44% to -$215007.0 in 2024, then jumped by 160.14% to $129306.0 in 2025, then tumbled by 104.65% to -$6019.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$6019.0 (Q1 2026), $129306.0 (Q4 2025), and -$171727.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,019.00 |
| Mar 31, 2026 | -6,019.00 |
| Dec 31, 2025 | 129,306.00 |
| Dec 31, 2025 | 129,306.00 |
| Sep 30, 2025 | -171,727.00 |
| Sep 30, 2025 | -171,727.00 |
| Jun 30, 2025 | -150,601.00 |
| Jun 30, 2025 | -150,601.00 |
| Mar 31, 2025 | -140,859.00 |
| Mar 31, 2025 | -140,859.00 |
| Dec 31, 2024 | -215,007.00 |
| Dec 31, 2024 | -215,007.00 |
| Sep 30, 2024 | -148,048.00 |
| Sep 30, 2024 | -148,048.00 |
| Jun 30, 2024 | 171,415.00 |
| Jun 30, 2024 | 171,415.00 |
| Mar 31, 2024 | 41,315.00 |
| Mar 31, 2024 | 41,315.00 |
| Dec 31, 2023 | -703,542.00 |
| Dec 31, 2023 | -703,542.00 |